Back to Journals » OncoTargets and Therapy » Volume 12

Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer

Total article views   HTML views PDF downloads Totals
7,353 Dovepress* 6,114+ 1,308 7,422
PubMed Central* 1,239 292 1,531
Totals 7,353 1,600 8,953
*Since 14 August 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar